(R)-Bambuterol
(R)-Bambuterol structure
|
Common Name | (R)-Bambuterol | ||
|---|---|---|---|---|
| CAS Number | 788821-30-7 | Molecular Weight | 367.45 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H29N3O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (R)-BambuterolBambuterol is a prodrug of β2-agonist commonly used for the treatment of asthma and chronic obstructive pulmonary disease (COPD) with the advantage of once daily dosing and favorable side effect profile. Administration of a single-dose of R-bambuterol resulted in dose-dependent reductions in the levels of plasma LDL-C, high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), apolipoprotein B (ApoB) and apolipoprotein A1 (ApoA1) at Tmax. R-bambuterol can lower the plasma levels of LDL-C, and marginally raise the ratio of ApoA1/ApoB (indicator of HDL-C/LDL-C) with both a single dose and multiple doses. R-bambuterol was more potent in LDL-C lowering than rac-bambutero |
| Name | (R)-Bambuterol |
|---|
| Description | Bambuterol is a prodrug of β2-agonist commonly used for the treatment of asthma and chronic obstructive pulmonary disease (COPD) with the advantage of once daily dosing and favorable side effect profile. Administration of a single-dose of R-bambuterol resulted in dose-dependent reductions in the levels of plasma LDL-C, high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), apolipoprotein B (ApoB) and apolipoprotein A1 (ApoA1) at Tmax. R-bambuterol can lower the plasma levels of LDL-C, and marginally raise the ratio of ApoA1/ApoB (indicator of HDL-C/LDL-C) with both a single dose and multiple doses. R-bambuterol was more potent in LDL-C lowering than rac-bambutero |
|---|
| Molecular Formula | C18H29N3O5 |
|---|---|
| Molecular Weight | 367.45 |